Ratings Health Italia S.p.A.

Equities

Market Closed - Borsa Italiana Other stock markets 16:44:59 29/05/2024 BST			5-day change	1st Jan Change
119 ^EUR	-2.46%		-1.65%	-1.65%

03-19	Futures passive; BoJ abandons negative rates.	AN
03-18	Milan at parity; De Nora on bottom after accounts	AN

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

The stock, which is currently worth 2024 to 0.59 times its sales, is clearly overvalued in comparison with peers.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
HEALTH ITALIA S.P.A.	-1.65%	24.81M		-
ODONTOPREV S.A.	-1.98%	1.21B		B

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality